News

12/08/2009	Memgen's ISF35 Sensitizes Cancer Cells to Chemotherapy Positive data evaluating ISF35 in combination with chemotherapy in resistant chronic lymphocytic leukemia (CLL) were presented December 7 at ASH
12/01/2009	Memgen's Clinical Trial Results of ISF35 for Chronic Lymphocytic Leukemia Selected for Presentation at ASH 2009 Annual Meeting Results from a recent clinical trial of ISF35 will be presented at the annual meeting of the American Society of Hematology (ASH) on December 7 in New Orleans.
06/04/2009	ASCO Presentation Highlights Memgen's ISF35 Anti-Cancer Activity in Chronic Lymphocytic Leukemia Results from the latest clinical trials completed with ISF35 were presented at the American Society of Clinical Oncology annual meeting on June 1 in Orlando.
06/04/2009	Memgen Reports Positive Results for ISF35 in High-Risk Chronic Lymphocytic Leukemia Phase Ib study of ISF35 has produced positive results, including a complete remission in the trial's first patient who had 17p deleted chronic lymphocytic leukemia (CLL).
05/26/2009	Memgen's ISF35 Clinical Trial Featured at ASCO Annual 2009 Meeting Results from a recent clinical trial of ISF35 will be presented at the annual meeting of the American Society of Clinical Oncology June 1 in Orlando.
12/03/2008	Memgen's Clinical Results on Leukemia Selected for Presentation at 2008 ASH Annual Meeting Memgen's CLL clinical trials at UCSD and M.D. Anderson will be presented at ASH, Dec. 6-9
11/03/2008	Moores UCSD Cancer Center Studying Novel Leukemia Vaccine for High-Risk Patients UCSD begins new Phase I clinicial trial of ISF35 in high risk CLL patients
06/18/2008	The Leukemia & Lymphoma Society, Memgen Collaborate on CLL Clinical Trial The Leukemia & Lymphoma Society (LLS) and Memgen collaborate on a new Phase I clinical trial for CLL.
06/09/2008	Dr. Kipps Featured on Leukemia and Lymphoma Society Program on June 25 Dr. Kipps, the inventor of Memgen's ISF35, will present an update on CLL therapy on Wed., June 25, 2008.
12/17/2007	UCSD Launches Vaccine Therapy Trial for Chronic Lymphocytic Leukemia (CLL) Patients with CLL who have failed chemotherapy or have chosen to forego it have an opportunity to participate in a clinical trial at UCSD.